Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Viatris weighs sale of European consumer health business — report
3 years ago
Deals
Pharma
Additional manufacturers in short supply of generic Adderall
3 years ago
Pharma
Manufacturing
Moderna gets Autolus targeting tech via licensing deal; Atai reports PhI data for kratom-based therapy
3 years ago
News Briefing
Merck pays Moderna $250M to continue Keytruda, cancer vaccine combo studies
3 years ago
Deals
R&D
Now with positive PhI data, DICE goes after public offering in search of $250M
3 years ago
Financing
Despite $109M influx in August, GreenLight Biosciences brings out the axe to chop a quarter of its staff
3 years ago
People
R&D
With help from Lululemon founder’s venture philanthropy, Vita adds second muscular dystrophy indication to lineup
3 years ago
Financing
R&D
Evofem's approved birth control gel flops PhIII for STI prevention, early 2023 filing plans ditched
3 years ago
R&D
Atlas-backed biotech focused on Huntington's disease shuts down less than three years after launch
3 years ago
R&D
Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t
3 years ago
Financing
Deals
Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico
3 years ago
Deals
AI
‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout
3 years ago
Startups
Deals
Michael Ehlers and Romesh Subramanian launch biotech with $50M, sea squirt-inspired RNA-editing tech
3 years ago
Financing
Startups
Now bankrupt, Zosano sells off its drug delivery tech that once enticed Novo Nordisk, Eli Lilly
3 years ago
Deals
Sangamo gives another update on early-stage Fabry program, enters trial expansion phase
3 years ago
R&D
Cell/Gene Tx
FDA settles drug compounding suit, agrees to speed its review of bulk ingredients
3 years ago
FDA+
Manufacturing
Walmart buys into pharma research, following in footsteps of CVS and Walgreens
3 years ago
Pharma
Amneal lays off more than a dozen employees at Long Island facility as operations wind down
3 years ago
Manufacturing
FDA signs off on GSK label expansion for Tdap vaccine
3 years ago
FDA+
More early data manipulation issues tied to Novartis blockbuster as Nature retracts paper
3 years ago
R&D
Cell/Gene Tx
AstraZeneca and GSK settle talent feud in court — again
3 years ago
People
Pharma
MarketingRx roundup: Pharma, agencies turn up for World Mental Health Day; Horizon, Vertex make best workplace list
3 years ago
Pharma
Marketing
#PharmaTok: Amgen, AZ join growing number of pharma marketers on the social video channel
3 years ago
Pharma
Marketing
Pfizer exec denies vaccine negotiations via text message in grilling before European Parliament
3 years ago
Deals
Pharma
First page
Previous page
446
447
448
449
450
451
452
Next page
Last page